2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An Update
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-12
DOI
10.3389/fphar.2022.899633
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global impact of delta plus variant and vaccination
- (2022) Vivek P Chavda et al. Expert Review of Vaccines
- A global picture: therapeutic perspectives for COVID-19
- (2022) Vivek P Chavda et al. Immunotherapy
- Omicron Variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
- (2022) Vivek P Chavda et al. MATURITAS
- Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
- (2022) Vivek P. Chavda et al. Vaccines
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
- (2021) Vivek P. Chavda et al. DRUG DISCOVERY TODAY
- Mucormycosis – An opportunistic infection in the aged immunocompromised individual: A reason for concern in COVID-19
- (2021) Vivek P. Chavda et al. MATURITAS
- Advanced Computational Methodologies Used in the Discovery of New Natural Anticancer Compounds
- (2021) Vivek P. Chavda et al. Frontiers in Pharmacology
- A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals
- (2021) Vivek P Chavda et al. Vaccines
- DNA vaccines for SARS-CoV-2: toward third-generation vaccination era
- (2021) Vivek P Chavda et al. Expert Review of Vaccines
- Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy
- (2021) Denisa Bojkova et al. Metabolites
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
- (2020) Denisa Bojkova et al. NATURE
- Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?
- (2020) Franz Rödel et al. STRAHLENTHERAPIE UND ONKOLOGIE
- SARS-CoV-2 and the pandemic of COVID-19
- (2020) Md Tanveer Adil et al. POSTGRADUATE MEDICAL JOURNAL
- Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure
- (2020) George D. Wilson et al. RADIATION RESEARCH
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis
- (2020) Ana Campos Codo et al. Cell Metabolism
- A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management
- (2020) Amit Verma et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment
- (2020) Anant Parasher POSTGRADUATE MEDICAL JOURNAL
- Viral hijacking of cellular metabolism
- (2019) Shivani K. Thaker et al. BMC BIOLOGY
- 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents
- (2019) B. Pajak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Systems Radiopharmacotherapy: A Paradigm in Drug Repurposing with Immune Modulatory Potential
- (2018) R.V. Papineni et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Glycolysis inhibitor 2-deoxy-D-glucose suppresses carcinogen-induced rat hepatocarcinogenesis by restricting cancer cell metabolism
- (2014) ZHAOFA WANG et al. Molecular Medicine Reports
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Glycolysis inhibition by 2-deoxy-d-glucose reverts the metastatic phenotype in vitro and in vivo
- (2011) Joseph L. Sottnik et al. CLINICAL & EXPERIMENTAL METASTASIS
- 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion
- (2010) Haibin Xi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies
- (2010) Mark Stein et al. PROSTATE
- Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy
- (2009) BS Dwarakanath et al. Future Oncology
- A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growth
- (2008) M. Ralser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now